Donald J.  Spence net worth and biography

Donald Spence Biography and Net Worth

Director of Integer
Donald J. Spence retired in August 2019 as President and Chief Executive Officer of Ebb Therapeutics, a company in the business of developing and marketing medical products for the treatment of insomnia, a position he held since March 2017. He had been Chairman and Chief Executive Officer of Lake Region Medical, Inc. from 2010 until its acquisition by the Company in October of 2015. From 2005 to 2008, he served as President of the Sleep and Home Respiratory Group for Philips Respironics, and from 2008 to 2010 as Chief Executive Officer of Philips Home Healthcare Solutions. Prior to that, Mr. Spence spent eight years with GKN Sinter Metals, as Senior Vice President for Global Sales and Marketing from 1998 to 2001 and as President from 2001 to 2005. Prior to 1998, he served in a number of roles at BOC Group, PLC over a 15-year career at that company including President, Ohmeda Medical Systems from 1997 to 1998. Mr. Spence is a director of Vapotherm, Inc. and serves as the chair of its Compensation Committee and as a member of its Audit Committee. Mr. Spence also serves as a director of Linguaflex, Inc., which is a privately-held medtech company. Mr. Spence serves on the following Committees of the Board of Directors of Integer Holdings Corporation: Audit Committee, Compensation and Organization Committee, Technology Committee.

What is Donald J. Spence's net worth?

The estimated net worth of Donald J. Spence is at least $2.06 million as of September 11th, 2023. Mr. Spence owns 18,781 shares of Integer stock worth more than $2,058,210 as of April 27th. This net worth estimate does not reflect any other assets that Mr. Spence may own. Learn More about Donald J. Spence's net worth.

How do I contact Donald J. Spence?

The corporate mailing address for Mr. Spence and other Integer executives is 5830 Granite Parkway Suite 1150, Plano TX, 75024. Integer can also be reached via phone at (214) 618-5243 and via email at [email protected]. Learn More on Donald J. Spence's contact information.

Has Donald J. Spence been buying or selling shares of Integer?

Donald J. Spence has not been actively trading shares of Integer during the last quarter. Most recently, Donald J. Spence sold 6,500 shares of the business's stock in a transaction on Monday, September 11th. The shares were sold at an average price of $82.32, for a transaction totalling $535,080.00. Following the completion of the sale, the director now directly owns 18,781 shares of the company's stock, valued at $1,546,051.92. Learn More on Donald J. Spence's trading history.

Who are Integer's active insiders?

Integer's insider roster includes Pamela Bailey (Director), Anthony Borowicz (SVP), Joseph Dziedzic (CEO), Joseph Flanagan (EVP), Jean Hobby (Director), Carter Houghton (Insider), Bill Sanford (Director), and Donald Spence (Director). Learn More on Integer's active insiders.

Are insiders buying or selling shares of Integer?

In the last twelve months, insiders at the medical equipment provider sold shares 2 times. They sold a total of 10,125 shares worth more than $839,036.25. The most recent insider tranaction occured on September, 11th when Director Donald J Spence sold 6,500 shares worth more than $535,080.00. Insiders at Integer own 2.0% of the company. Learn More about insider trades at Integer.

Information on this page was last updated on 9/11/2023.

Donald J. Spence Insider Trading History at Integer

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/11/2023Sell6,500$82.32$535,080.0018,781View SEC Filing Icon  
3/13/2019Sell50,559$85.41$4,318,244.1941,285View SEC Filing Icon  
See Full Table

Donald J. Spence Buying and Selling Activity at Integer

This chart shows Donald J Spence's buying and selling at Integer by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Integer Company Overview

Integer logo
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Read More

Today's Range

Now: $109.59
Low: $107.11
High: $111.25

50 Day Range

MA: $113.11
Low: $98.56
High: $123.34

2 Week Range

Now: $109.59
Low: $69.40
High: $123.99

Volume

604,251 shs

Average Volume

342,875 shs

Market Capitalization

$3.67 billion

P/E Ratio

40.74

Dividend Yield

N/A

Beta

1.1